{"id":"W4366987477","doi":"10.51731/cjht.2023.630","title":"Caplacizumab (Cablivi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Clinical trial; Disease; Quality of life (healthcare); Intensive care medicine; Internal medicine; Oncology; Alternative medicine; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006605322,0.0001137444,0.0003318764,0.001097856,0.0003437669,0.00001896634,0.0005264925,0.0001400751,0.0003019866],"category_scores_gemma":[0.0005808881,0.00009928848,0.00008452139,0.0005324104,0.0002292187,0.00007733489,0.00003873969,0.0003029587,0.0005901182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002468039,"about_ca_system_score_gemma":0.001880674,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00299041,"about_ca_topic_score_gemma":0.003535107,"domain_scores_codex":[0.9985448,0.000118037,0.0005634176,0.0001202873,0.00003977074,0.0006136642],"domain_scores_gemma":[0.9991291,0.0001068834,0.000352028,0.0002693584,0.0001083772,0.00003428092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002229507,0.00002093051,0.02299996,0.0001546149,0.000189166,0.0002422464,0.0005424275,0.00002857078,0.001002402,0.004342531,0.6201153,0.3503396],"study_design_scores_gemma":[0.0007119188,0.0003265035,0.02716896,0.0002428082,0.00001349188,0.0005004416,0.007919103,0.000001520248,0.001399247,0.003406949,0.9581398,0.0001691972],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7510526,0.1952881,0.0001072153,0.0465149,0.004436186,0.0005504507,0.0002180465,0.0009749903,0.0008575423],"genre_scores_gemma":[0.9991533,0.0002107602,0.00002558034,0.0001409208,0.000005750117,0.000007401641,0.00001636078,0.00001158075,0.0004283473],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3501704,"threshold_uncertainty_score":0.7584972,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03892056565294667,"score_gpt":0.2855324157177698,"score_spread":0.2466118500648231,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}